These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


596 related items for PubMed ID: 17101176

  • 1. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW, Waage C, Fure H, Brekke OL, Sfyroera G, Lambris JD, Mollnes TE.
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [Abstract] [Full Text] [Related]

  • 2. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
    Kerr FK, Thomas AR, Wijeyewickrema LC, Whisstock JC, Boyd SE, Kaiserman D, Matthews AY, Bird PI, Thielens NM, Rossi V, Pike RN.
    Mol Immunol; 2008 Feb; 45(3):670-7. PubMed ID: 17709141
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
    Salvesen B, Nielsen EW, Harboe M, Saugstad OD, Mollnes TE.
    Mol Immunol; 2009 Feb; 46(4):688-94. PubMed ID: 18950866
    [Abstract] [Full Text] [Related]

  • 4. Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.
    Hamad I, Hunter AC, Szebeni J, Moghimi SM.
    Mol Immunol; 2008 Dec; 46(2):225-32. PubMed ID: 18849076
    [Abstract] [Full Text] [Related]

  • 5. Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation.
    Kocsis A, Kékesi KA, Szász R, Végh BM, Balczer J, Dobó J, Závodszky P, Gál P, Pál G.
    J Immunol; 2010 Oct 01; 185(7):4169-78. PubMed ID: 20817870
    [Abstract] [Full Text] [Related]

  • 6. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
    Hair PS, Gronemus JQ, Crawford KB, Salvi VP, Cunnion KM, Thielens NM, Arlaud GJ, Rawal N, Krishna NK.
    Mol Immunol; 2010 Jan 01; 47(4):792-8. PubMed ID: 19896716
    [Abstract] [Full Text] [Related]

  • 7. Plasma-derived mannose-binding lectin shows a direct interaction with C1-inhibitor.
    Keizer MP, Kamp AM, Brouwer N, van de Wetering MD, Wouters D, Kuijpers TW.
    Mol Immunol; 2014 Apr 01; 58(2):187-93. PubMed ID: 24368318
    [Abstract] [Full Text] [Related]

  • 8. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
    Møller-Kristensen M, Thiel S, Sjöholm A, Matsushita M, Jensenius JC.
    Int Immunol; 2007 Feb 01; 19(2):141-9. PubMed ID: 17182967
    [Abstract] [Full Text] [Related]

  • 9. Recombinant C1 inhibitor in brain ischemic injury.
    Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, Vietsch H, Mannesse ML, Ziere B, Gobbi M, De Simoni MG.
    Ann Neurol; 2009 Sep 01; 66(3):332-42. PubMed ID: 19798727
    [Abstract] [Full Text] [Related]

  • 10. Activation of the alternative complement pathway by mannose-binding lectin via a C2-bypass pathway.
    Tateishi K, Matsushita M.
    Microbiol Immunol; 2011 Nov 01; 55(11):817-21. PubMed ID: 21831201
    [Abstract] [Full Text] [Related]

  • 11. Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.
    Skliris A, Happonen KE, Terpos E, Labropoulou V, Børset M, Heinegård D, Blom AM, Theocharis AD.
    Eur J Immunol; 2011 Feb 01; 41(2):437-49. PubMed ID: 21268013
    [Abstract] [Full Text] [Related]

  • 12. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency.
    Roos A, Garred P, Wildenberg ME, Lynch NJ, Munoz JR, Zuiverloon TC, Bouwman LH, Schlagwein N, Fallaux van den Houten FC, Faber-Krol MC, Madsen HO, Schwaeble WJ, Matsushita M, Fujita T, Daha MR.
    Eur J Immunol; 2004 Sep 01; 34(9):2589-98. PubMed ID: 15307191
    [Abstract] [Full Text] [Related]

  • 13. A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin.
    Inoshita H, Matsushita M, Koide S, Kusaba G, Ishii M, Onda K, Gi MJ, Nakata M, Ohsawa I, Horikoshi S, Ohi H, Tomino Y.
    J Immunol Methods; 2009 Sep 30; 349(1-2):9-17. PubMed ID: 19699205
    [Abstract] [Full Text] [Related]

  • 14. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
    Groeneveld TW, Ramwadhdoebé TH, Trouw LA, van den Ham DL, van der Borden V, Drijfhout JW, Hiemstra PS, Daha MR, Roos A.
    Mol Immunol; 2007 Jul 30; 44(14):3608-14. PubMed ID: 17448537
    [Abstract] [Full Text] [Related]

  • 15. Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis.
    Hisano S, Matsushita M, Fujita T, Takeshita M, Iwasaki H.
    Pathol Int; 2007 Jun 30; 57(6):351-7. PubMed ID: 17539966
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F, Kijlstra A.
    Immunology; 1985 Mar 30; 54(3):449-56. PubMed ID: 3844370
    [Abstract] [Full Text] [Related]

  • 17. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
    Schwertz H, Carter JM, Russ M, Schubert S, Schlitt A, Buerke U, Schmidt M, Hillen H, Werdan K, Buerke M.
    J Cardiovasc Pharmacol; 2008 Aug 30; 52(2):151-60. PubMed ID: 18670364
    [Abstract] [Full Text] [Related]

  • 18. The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification.
    Harboe M, Garred P, Karlstrøm E, Lindstad JK, Stahl GL, Mollnes TE.
    Mol Immunol; 2009 Dec 30; 47(2-3):373-80. PubMed ID: 19800125
    [Abstract] [Full Text] [Related]

  • 19. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway.
    Iwaki D, Kanno K, Takahashi M, Endo Y, Matsushita M, Fujita T.
    J Immunol; 2011 Oct 01; 187(7):3751-8. PubMed ID: 21865552
    [Abstract] [Full Text] [Related]

  • 20. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
    Cestari Idos S, Krarup A, Sim RB, Inal JM, Ramirez MI.
    Mol Immunol; 2009 Dec 01; 47(2-3):426-37. PubMed ID: 19783051
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.